Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers

Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, Harbin 150081, China; Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, Harbin 150081, China Contributions: (I) Conception and design: H Zhou, Q Li, T Wang; (II) Administrative support: T Wang; (III) Provision of study materials or patients: Q Li, M Song, Y Wang, H Jin; (IV) Collection and assembly of data: H Zhou, H Liang, Y Wang, Y Duan; (V) Data analysis and interpretation: H Zhou, T Wang; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. Correspondence to: Prof. Tong Wang, PhD. Institute of Keshan Disease, Chinese Center for Endemic Disease Control, Harbin Medical University, 157 Baojian Road, Harbin 150081, China. Email: wangtong@ems.hrbmu.edu.cn; Prof. Qi Li, MD, PhD. Department of Gynecological Radiotherapy, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150081, China. Email: liqi@ems.hrbmu.edu.cn.